Galantamine
NDC 57237-051, Galantamine, tablet, film coated, from Rising Pharma Holdings, Inc..
- Product NDC
- 57237-051
- Status
- Listed
- Labeler
- Rising Pharma Holdings, Inc.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA090957
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/57237-051 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GALANTAMINE HYDROBROMIDE12 mg/1
Pharmacologic classes
Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 57237-051-60 | 57237005160 | 60 TABLET, FILM COATED in 1 BOTTLE (57237-051-60) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/a0dc1a93-b7b8-4179-8ea7-ceecbe1ef243NADAC price for package 57237005160
GET /v1/drugs/nadac/57237005160
Use it
Look up 57237-051 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/57237-051 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 57237-051. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.